StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Roche Holding AG
Swiss Stock Exchange:RO.SW
Sector
Location
Market Cap
USD 260.18 B
Share Price
USD 344.49
Avg Daily Volume
39,406
Change (1 day)
-0.92%
Change (1 year)
14.41%
Change (YTD)
15.13%
Roche Holding AG Gross Profit Margin for the year ending December 31, 2024: 73.90%
Roche Holding AG Gross Profit Margin is 73.90% for the year ending December 31, 2024, a 1.32% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Roche Holding AG Gross Profit Margin for the year ending December 31, 2023 was 72.94%, a 3.85% change year over year.
-
Roche Holding AG Gross Profit Margin for the year ending December 31, 2022 was 70.23%, a 2.34% change year over year.
-
Roche Holding AG Gross Profit Margin for the year ending December 31, 2021 was 68.63%, a -4.63% change year over year.
-
Roche Holding AG Gross Profit Margin for the year ending December 31, 2020 was 71.96%, a -1.06% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.20
MRK.DE
-2.77
-2.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Alnylam Pharmaceuticals, Inc.
USD 331.91
ALNY
+2.14
0.65%
Key Data
| Date | Gross Profit Margin | EBIT Margin | EBITDA Margin | Net Income Margin |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.20
MRK.DE
-2.77
-2.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Alnylam Pharmaceuticals, Inc.
USD 331.91
ALNY
+2.14
0.65%